Business Wire

Svante Celebrates 18 Years of Carbon Management Innovation with Historic Milestones in 2025

30.10.2025 17:25:00 CET | Business Wire | Press Release

Share

Svante Technologies Inc. (Svante), a global leader in carbon capture and removal solutions, proudly marks its 18th anniversary this month, celebrating nearly two decades of pioneering industrial carbon management technology. This year has been one of the most transformative in Svante’s history, defined by bold innovation, strategic partnerships, and the commissioning of the world’s first commercial manufacturing facility for solid sorbent-based carbon capture and removal filters.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030974500/en/

Founded in 2007 with a vision to revolutionize how the world manages carbon dioxide emissions, Svante has grown into a cornerstone of the global carbon management industry. In 2025, that vision took a monumental leap forward with the launch of the Redwood Facility in Burnaby, BC — a 141,000-square-foot Centre of Excellence for Carbon Capture and Removal. This first-of-its-kind manufacturing factory is designed to produce enough solid sorbent-based filters to capture up to 10 million tonnes of CO₂ annually, equivalent to removing the emissions of more than 2.7 million gas-powered cars.

“This year, we didn’t just celebrate our past — we made a bold statement that we are ready to commercialize and to build a sustainable future,” said Claude Letourneau, President & CEO of Svante. “The commissioning of Redwood is more than a milestone; it’s a signal to the world that scalable, environmentally responsible, high-performance carbon capture and removal technology is here, and it’s Canadian-made.”

The Redwood Facility is powered by Svante’s patented structured adsorbent filters, coated in metal-organic frameworks (MOFs) and other solid sorbent nanomaterials, representing a generational leap in industrial carbon capture and removal. These filters are now being deployed in major projects, including:

  • Chevron’s Kern River facility in California, U.S.A.
  • Project CO₂MENT with Lafarge Holcim at the Richmond Cement Plant in BC, Canada
  • A number of pilot and commercial scale direct air capture (DAC) facilities utilizing Svante’s structured filter technologies.

Svante also advanced its joint carbon capture project with Mercer International to the Pre-FEED stage at Mercer’s Peace River pulp mill in Alberta, targeting biogenic CO₂ emissions from sustainably sourced biomass. Further, Svante is ready to enter the FEED stage at the Delek US’s Big Spring Refinery in Texas, U.S.A.

In addition to the company’s technical milestones over the years, Svante has secured approximately US $600 million in capital investment from strategic partners and investors like Chevron New Energies, Temasek, M&G, United Airlines Ventures, GE Vernova, Samsung Venture Investment, Canada Growth Fund and InBC. The funding Svante has received through the years supported the company’s product industrialization, the scaling of Svante’s manufacturing capabilities, and the development of future facilities and technologies to meet global demand.

As part of its 18-year anniversary celebration, Svante hosted a GO25in May this year, a two-day grand opening event that brought together industry leaders, investors, and policymakers from around the world to explore the future of carbon management. Panels and fireside chats featured voices from Amazon, BMO, JPMorganChase, CGF, Climate Investment, Carbon Direct, SAMSUNG E&A, and Emissions Reduction Alberta, highlighting Svante’s leadership in commercialization, project development, and Canadian climate innovation.

In 2025, Svante made other announcements, including:

Looking ahead, Svante remains committed to accelerating the deployment of its engineered carbon management solutions across the biogenic, heavy industry, and energy sectors by, as Letourneau says, “cracking the code” on CO2 monetization.

About Svante
Svante is a purpose-driven, leading carbon capture and removal solutions provider. The company makes nanoengineered filters and modular rotating contactor machines that capture and remove CO2 in an environmentally responsible way from industrial emissions and the air. Svante is on the 2025 Global Cleantech 100 and TIME & Statista’s list of Top Greentech Companies of 2025. For more information, visit www.svanteinc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251030974500/en/

Contacts

Media Contact:
Colleen Nitta
Director, Marketing & Communications
cnitta@svanteinc.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye